ArticleCureus2025
Acute Kidney Injury and Viral Myocarditis Secondary to Acute Epstein-Barr Virus Infection.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epstein-Barr virus (EBV) typically causes a self-limiting disease characterized by fever, pharyngitis, and lymphadenopathy. Clinically overt renal and cardiac involvement is rare, and its presentation ranges from subclinical manifestations to severe organ dysfunction. In cases where renal biopsies have been performed, the most common pathology identified is interstitial nephritis. We report a case of a 24-year-old male with a history of recurrent tonsillitis - the most recent episode occurring one month prior - who presented to the Emergency Department with a three-day symptom of asthenia, diffuse abdominal pain, and vomiting. His blood tests showed acute kidney injury (AKI) and elevated natriuretic peptide levels, with negative troponin levels. Viral markers were consistent with primary EBV infection. Renal biopsy revealed moderate acute tubular necrosis, with no glomerular injury. Renal function showed signs of improvement within the initial three days following the initiation of fluid therapy. Given the high index of clinical suspicion, a cardiac MRI was performed, revealing myocarditis. This case underscores the potential for EBV to present with AKI and myocarditis, contributing valuable insights into the diverse clinical manifestations of EBV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.